Buscar resultados de ensayos clínicos
Monoclonal Gammopathy of Undetermined Significance - 25 Studies Found
Estado | Estudiar |
Suspended |
Nombre del estudio: Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance Condición:
|
Completed |
Nombre del estudio: Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) Condición:
|
Recruiting |
Nombre del estudio: Unravel MGUS (Monoclonal Gammopathy of Unknown Significance) Condición: Monoclonal Gammopathy of Unknown Significance Fecha: 2016-09-15 Intervenciones:
|
Completed |
Nombre del estudio: A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma Condición:
|
Completed |
Nombre del estudio: Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy Condición:
|
Active, not recruiting |
Nombre del estudio: Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. Condición:
|
Recruiting |
Nombre del estudio: Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies Condición:
|
Terminated |
Nombre del estudio: Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance Condición: Precancerous Condition Fecha: 2007-12-20 Intervenciones: Biological: Rituximab Rituximab will be given as a 375 mg/m^2 intravenous infusion once weekly for four |
Not yet recruiting |
Nombre del estudio: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat Condición:
|